Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 3 Piperidone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103613531B details Pd/C catalyzed synthesis yielding 50-65%. Offers simplified route for pharmaceutical intermediates manufacturing with significant cost and supply chain advantages.
Novel 4-step synthesis of N-alkyl-3-piperidones from cyclopropyl methyl ketone. High yield, scalable process for pharmaceutical intermediates avoiding column chromatography.
Novel iridium hydrogenation method for high-purity 3-piperidone derivatives. Offers superior selectivity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN109182410B details a high-yield biocatalytic route for chiral piperidine intermediates, offering significant cost reduction in API manufacturing and superior supply chain reliability.
Patent CN105209436B reveals biomass-derived route for high-purity 3-piperidone. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN103304472A details a high-yield synthesis of 1-BOC-3-piperidone via Oppenauer oxidation, offering significant cost reduction in API manufacturing and scalable production capabilities.
Patent CN105622444B details a novel synthesis route for 1-benzyl-3-piperidone hydrochloride offering high purity and cost-effective manufacturing for global pharmaceutical supply chains.
Patent CN105622444B reveals a novel route for 1-benzyl-3-piperidone hydrochloride. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing without noble metals.